Atlas Trials

Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT03238365 · COMPLETED

Trial details

NCT number
NCT03238365
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Lip, Oral Cavity and PharynxLarynx
Start date
2017-08-10
Primary completion
2019-07-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.